Literature DB >> 8951616

Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.

H Shibuya-Saruta1, Y Kasahara, Y Hashimoto.   

Abstract

Dipeptidyl peptidase IV (DPPIV, EC 3.4.14.5) has been purified 18,000-fold in a yield of 2.2% from human serum. Serum DPPIV, a serine enzyme with an apparent mass of 250 kDa, consists of two identical subunits with an apparent mass of 100 kDa and is inhibited by DPPIV-specific inhibitor Diprotin A and also by p-chloromercuribenzoate (p-CMB), 2-mercaptoethanol, HgCl2, CdCl2, SrCl2, and ZnCl2. One of the remarkable properties of DPPIV is that its activity is greatly enhanced by Gly-X (X: especially, Gly, Gln, Glu and Ser) dipeptides. Gly-X dipeptides increase not only an apparent Km of serum DPPIV for glycyl-L-proline 3,5-dibromo-4-hydroxyanilide nearly 10-fold, but also an apparent kcat nearly 4-fold. This mechanism is unclear, but one possibility is that Gly-Pro from substrate might bind amino acids or dipeptides instead of water molecules as DPPIV transpeptidyl activity reported previously. Another remarkable property of DPPIV is the ability to bind adenosine deaminase-I and -II, as is the case with recombinant soluble CD26 (rsCD26). This probably indicates that DPPIV purified from human serum by our method originates from T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951616     DOI: 10.1002/(SICI)1098-2825(1996)10:6<435::AID-JCLA21>3.0.CO;2-X

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  4 in total

1.  Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.

Authors:  Miguel Cuchacovich; Héctor Gatica; Paula Vial; Jorge Yovanovich; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

Authors:  M Gonzalez-Gronow; H E Grenett; M R Weber; G Gawdi; S V Pizzo
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

3.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

4.  Magnetic ligand fishing using immobilized DPP-IV for identification of antidiabetic ligands in lingonberry extract.

Authors:  Rita de Cássia Lemos Lima; Ulrike Böcker; Gordon J McDougall; J William Allwood; Nils Kristian Afseth; Sileshi Gizachew Wubshet
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.